Evommune (NYSE: EVMN) is ending development of EVO756 in chronic spontaneous urticaria after the oral MRGPRX2 antagonist failed a mid-stage…
Browsing: Biotechnology
The world’s largest buyer of biopharmaceutical royalties has set up its first Asia-Pacific base in Hong Kong, joining a string…
More than 200 European biotech companies, investment funds and organisations are calling on EU leaders to take urgent action to…
Liu Da, managing director of the CR-CP Life Science Fund and chairman of the Hong Kong Life Sciences Investment Association,…
As the European Union advances a series of major health and industrial reforms, Poland has voiced support for new legislation…
Abu Dhabi has joined forces with a leading US biotechnology company to test a cutting-edge cancer treatment.Clinical trials in the…
Merck KGaA agrees $11.3bn deal in major life sciences expansion Life Sciences Intellectual Property Review Source link
Viking Therapeutics Inc (VKTX:NASDAQ) is moving forward with a new clinical program aimed at weight management, adding another candidate to…
Biotechnology has entered an era of unprecedented creativity where the boundaries between science fiction and reality blur with each new…
This insight was delivered by Quantisnow – Wall Street’s wire, on your screen. Quantisnow is a real-time market data and…